Two New TCR-NK Cell Therapy Trials Now Recruiting for Synovial Sarcoma
Two clinical trials testing TCR-NK cell therapy for advanced synovial sarcoma are now recruiting patients, one in the United States…
The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma
A new study published in PLOS One by Ji-Yong Sung, Jin-Hong Kim, and Yi-Jun Kim from Seoul National University and…
Synovial Sarcoma Foundation Launches Ambassador Program During Childhood Cancer Awareness Month
New program invites patients, survivors, caregivers, and families to turn lived experience into advocacy. [Philadelphia, PA], September 1, 2026: This…
How Better T Cell Manufacturing Could Unlock the Next Wave of Synovial Sarcoma Therapies
A study published in Cytotherapy by Kayo Toishigawa, Kenta Magoori, Hiroyuki Sato, and colleagues at Hiroshima University, in collaboration with…
Why a Melanoma Vaccine Breakthrough Matters for Synovial Sarcoma
Merck and Moderna are making headlines after their personalized mRNA cancer vaccine entered Phase 3 clinical trials for melanoma. For…
A New CAR-T Cell Approach for Synovial Sarcoma That Does Not Require HLA Matching
A new preclinical study published in Biomedicine and Pharmacotherapy by Tomohiro Miyazaki, Yudai Murayama, Naoki Oike, and colleagues from the…
In Conversation with Kaela: How Research Gave a Mom of Two a Second Chance at Life
Kaela Graham-Bowman’s story reached national audiences this year when she was featured on 60 Minutes Australia. An Afghanistan veteran and…
World’s First MAGE-A4-Targeting TCR-NK Therapy Zelluna Doses First Patient in Clinical Trial
Zelluna ASA, a Norwegian biotech company pioneering allogeneic cell therapies for solid cancers, recently announced that the first patient has…
When Synovial Sarcoma Mimics the Heart’s Most Common Tumor
A case report in AME Case Reports by Yun Xiao, Zhourui Liu, and Sha Li of the Department of Ultrasound…